Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Sanofi/GSK Next-Generation COVID-19 Vaccine Shows Promise As Booster

Jun 13 2022

• By Alaric DeArment

Sanofi/GSK announced booster data for their next-generation COVID-19 vaccine candidate • Source: Shutterstock

Related Content

Coronavirus Update: Sanofi And GSK’s Vaccine Suffers Setback

Dec 11 2020

Coronavirus Update: Moderna’s Omicron Vaccine Study Successful, But Data Draw Skepticism

Jun 08 2022

Straggler Novavax Still Hopes To Hit Paydirt With Combo Vaccine

Apr 22 2022

Novavax Gains US FDA Advisory Committee Endorsement, But So Does Myocarditis Risk Statement

Jun 08 2022

Novavax’s Pending EUA Likely Less Important Than Future Updates

Jun 09 2022

Sanofi And GSK’s Much-Delayed COVID-19 Vaccine Ready To File, But Role Looks Limited

Feb 23 2022

Related Companies

Sanofi

Pfizer Inc.

BioNTech SE

Moderna, Inc.

Novavax, Inc.

Additional Topics

Coronavirus COVID-19 Vaccines Research & Development Infectious Diseases BioPharmaceutical

More from COVID-19

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window